Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros








Base de dados
Intervalo de ano de publicação
1.
Respir Med Res ; 76: 38-44, 2019 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-31527016

RESUMO

BACKGROUND: Patients with metastatic non-small-cell lung cancer (NSCLC) who survive more than 2 years are considered long-term survivors (LTSs). The present study examined factors associated with long-term survival and collected information for future comparison. METHODS: Clinical, molecular, and therapeutic data were collected from patients followed for primary stage IV (7th TNM classification) NSCLC within 2 years from diagnosis in the respiratory medicine departments of 53 French non-teaching hospitals. LTS and non-LTS records were compared. Factors associated with long-term survival were examined by univariate and multivariate analyses using logistic regression models. RESULTS: Vital status at least 2 years after diagnosis was known for 1977 stage IV NSCLC patients; 220 (11.1%) were LTSs. On multivariate analysis, independent positive factors comprised: TTF-1(+) immunochemistry, EGFR-mutation, surgery, rescue radiotherapy, and targeted therapy. Independent negative factors comprised: prediagnosis weight loss>5kg, ECOG performance status>1, and primary radiotherapy. CONCLUSIONS: Molecular biology and targeted therapy were decisive for long-term survival. With their development and their widespread implementation in clinical practice, the percentage of LTSs is expected to grow. Factors determining long-term survival found in this study should be taken into account when considering treatment options for patients with stage IV NSCLC.


Assuntos
Carcinoma Pulmonar de Células não Pequenas , Neoplasias Pulmonares , Adulto , Idoso , Idoso de 80 Anos ou mais , Biomarcadores Tumorais/genética , Carcinoma Pulmonar de Células não Pequenas/genética , Carcinoma Pulmonar de Células não Pequenas/mortalidade , Carcinoma Pulmonar de Células não Pequenas/patologia , Carcinoma Pulmonar de Células não Pequenas/terapia , Feminino , França/epidemiologia , Predisposição Genética para Doença , Humanos , Neoplasias Pulmonares/genética , Neoplasias Pulmonares/mortalidade , Neoplasias Pulmonares/patologia , Neoplasias Pulmonares/terapia , Masculino , Pessoa de Meia-Idade , Metástase Neoplásica , Estadiamento de Neoplasias , Prognóstico , Fatores de Risco , Análise de Sobrevida
2.
Rev Mal Respir ; 27(4): 341-7, 2010 Apr.
Artigo em Francês | MEDLINE | ID: mdl-20403544

RESUMO

Laparoscopic gastroplasty with an adjustable band is an efficient treatment of morbid obesity. Pulmonary complications have been rarely reported. We differentiate early pulmonary complications (arising before the 30th postoperative day) and long-term pulmonary complications. These latter are often not recognised as linked to the gastroplasty due to inadequate follow-up, loss of contact and underestimation of the symptoms by patients. Long-term pulmonary complications occur in the context of oesophageal dilatation and develop, on average, 2 years after the procedure. The pulmonary complications are: chronic cough, pneumonia, lung abscess, interstitial pneumonia secondary to recurrent aspiration and bronchial aspiration during induction of anaesthesia. Deflation of the band may be necessary to relieve the symptoms, but sometimes at the price of a subsequent increase in weight.


Assuntos
Gastroplastia/efeitos adversos , Pneumopatias/etiologia , Complicações Pós-Operatórias , Seguimentos , Humanos , Laparoscopia/efeitos adversos , Abscesso Pulmonar/etiologia , Pneumonia Aspirativa/etiologia , Aspiração Respiratória/etiologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA